Formosa Laboratories Future Growth
Future criteria checks 1/6
Formosa Laboratories is forecast to grow revenue at 13.9% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 36.3% |
| Revenue growth rate | 13.9% |
| Future return on equity | 12.3% |
| Analyst coverage | Low |
| Last updated | 01 Apr 2024 |
Recent future growth updates
Recent updates
Benign Growth For Formosa Laboratories, Inc. (TWSE:4746) Underpins Its Share Price
Apr 19
Here's Why Formosa Laboratories (TPE:4746) Has A Meaningful Debt Burden
Apr 19Does Formosa Laboratories, Inc.'s (TPE:4746) Weak Fundamentals Mean A Downturn In Its Stock Should Be Expected?
Mar 16What Type Of Returns Would Formosa Laboratories'(TPE:4746) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?
Feb 08Formosa Laboratories (TPE:4746) Is Making Moderate Use Of Debt
Jan 11
Formosa Laboratories's (TPE:4746) Earnings Are Growing But Is There More To The Story?
Dec 13Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 5,770 | N/A | 470 | 1,309 | 1 |
| 12/31/2024 | 5,089 | 706 | 101 | 939 | 1 |
| 12/31/2023 | 4,360 | 126 | 286 | 827 | N/A |
| 9/30/2023 | 4,216 | 270 | 233 | 728 | N/A |
| 6/30/2023 | 4,111 | 876 | 91 | 534 | N/A |
| 3/31/2023 | 3,863 | 785 | 206 | 658 | N/A |
| 12/31/2022 | 3,766 | 409 | 203 | 643 | N/A |
| 9/30/2022 | 3,586 | -94 | -72 | 349 | N/A |
| 6/30/2022 | 3,252 | -970 | -162 | 315 | N/A |
| 3/31/2022 | 3,241 | -217 | -152 | 350 | N/A |
| 12/31/2021 | 3,142 | 1,249 | -203 | 311 | N/A |
| 9/30/2021 | 3,064 | 1,293 | -196 | 356 | N/A |
| 6/30/2021 | 3,189 | 1,778 | -93 | 491 | N/A |
| 3/31/2021 | 3,149 | 1,568 | -370 | 400 | N/A |
| 12/31/2020 | 3,075 | 400 | -536 | 475 | N/A |
| 9/30/2020 | 2,987 | 460 | -809 | 534 | N/A |
| 6/30/2020 | 2,962 | 531 | -1,103 | 360 | N/A |
| 3/31/2020 | 2,768 | -122 | -850 | 489 | N/A |
| 12/31/2019 | 2,760 | 12 | -1,134 | 287 | N/A |
| 9/30/2019 | 2,735 | 188 | -1,121 | 83 | N/A |
| 6/30/2019 | 2,630 | -108 | -1,137 | 0 | N/A |
| 3/31/2019 | 2,729 | 38 | -1,202 | -123 | N/A |
| 12/31/2018 | 2,688 | 177 | -1,082 | -81 | N/A |
| 9/30/2018 | 2,659 | 103 | -814 | 66 | N/A |
| 6/30/2018 | 2,600 | 266 | -605 | 140 | N/A |
| 3/31/2018 | 2,575 | 358 | -491 | 136 | N/A |
| 12/31/2017 | 2,539 | 239 | -78 | 395 | N/A |
| 9/30/2017 | 2,651 | 347 | N/A | 672 | N/A |
| 6/30/2017 | 2,793 | 404 | N/A | 889 | N/A |
| 3/31/2017 | 3,022 | 431 | N/A | 1,102 | N/A |
| 12/31/2016 | 3,189 | 483 | N/A | 1,110 | N/A |
| 9/30/2016 | 3,280 | 457 | N/A | 849 | N/A |
| 6/30/2016 | 3,225 | 474 | N/A | 628 | N/A |
| 3/31/2016 | 2,813 | 345 | N/A | 404 | N/A |
| 12/31/2015 | 2,597 | 282 | N/A | 255 | N/A |
| 9/30/2015 | 2,252 | 231 | N/A | 300 | N/A |
| 6/30/2015 | 2,115 | 206 | N/A | 286 | N/A |
| 3/31/2015 | 2,416 | 248 | N/A | 340 | N/A |
| 12/31/2014 | 2,496 | 262 | N/A | 280 | N/A |
| 9/30/2014 | 2,710 | 252 | N/A | 268 | N/A |
| 6/30/2014 | 2,852 | 207 | N/A | 289 | N/A |
| 3/31/2014 | 2,845 | 150 | N/A | -123 | N/A |
| 12/31/2013 | 2,474 | -69 | N/A | 32 | N/A |
| 9/30/2013 | 2,329 | -139 | N/A | -120 | N/A |
| 6/30/2013 | 2,279 | -203 | N/A | -206 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 4746's forecast earnings growth is above the savings rate (1%).
Earnings vs Market: Insufficient data to determine if 4746's earnings are forecast to grow faster than the TW market
High Growth Earnings: Insufficient data to determine if 4746's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 4746's revenue (13.9% per year) is forecast to grow faster than the TW market (10.6% per year).
High Growth Revenue: 4746's revenue (13.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4746's Return on Equity is forecast to be low in 3 years time (12.3%).